COVID-19 outbreak among French firefighters, Marseille, France, 2020.

COVID-19 SARS-CoV-2 asymptomatic neutralisation assay presymptomatic serology

Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
10 2021
Historique:
entrez: 15 10 2021
pubmed: 16 10 2021
medline: 21 10 2021
Statut: ppublish

Résumé

We investigated a COVID-19 outbreak at a fire station in Marseille, France. Confirmed cases were defined as individuals with positive SARS-CoV-2 reverse transcription (RT)-PCR and/or neutralising antibodies. All 85 firefighters at work during the outbreak period were included after questioning and sampled for RT-PCR and viral neutralisation assay. Twenty-three firefighters were confirmed positive, 19 of them were symptomatic, and four asymptomatic cases were confirmed by virus neutralisation. A total of 22 firefighters had specific neutralising antibodies against SARS-CoV-2. Neutralising antibodies were found in four asymptomatic and 18 symptomatic cases. Eleven symptomatic cases had high titres (≥ 1:80). The earliest detection of neutralising antibodies was 7 days after symptom onset, and 80% had neutralising antibodies 15 days after onset. One viral culture was positive 13 days after onset. The attack rate was 27%. We identified two introductions of the virus in this outbreak, through a presymptomatic and a paucisymptomatic case. Asymptomatic cases were not the source of a third generation of cases, although they worked without wearing a mask, indicating that asymptomatic cases did not play a significant role in this outbreak. Management and strategy based on early research of clinical signs associated with self-quarantine was effective.

Identifiants

pubmed: 34651571
doi: 10.2807/1560-7917.ES.2021.26.41.2001676
pmc: PMC8518307
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Med Virol. 2020 Jun;92(6):568-576
pubmed: 32134116
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Emerg Infect Dis. 2020 Jul;26(7):
pubmed: 32364890
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
Int J Biol Sci. 2020 Mar 15;16(10):1718-1723
pubmed: 32226289
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
J Infect. 2020 Jun;80(6):e1-e13
pubmed: 32283156
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Emerg Infect Dis. 2020 Oct;26(10):2484-2487
pubmed: 32579877
Wellcome Open Res. 2020 Apr 1;5:58
pubmed: 32685697
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
PLoS Med. 2020 Sep 22;17(9):e1003346
pubmed: 32960881
J Infect Dis. 2006 Mar 15;193(6):792-5
pubmed: 16479513
J Med Virol. 2021 Mar;93(3):1414-1420
pubmed: 32767703
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Science. 2020 Aug 14;369(6505):812-817
pubmed: 32434946
Emerg Infect Dis. 2020 Aug;26(8):1915-1917
pubmed: 32320641

Auteurs

Guillaume André Durand (GA)

French Armed Forces Biomedical Research Institute, National Reference Laboratory for Arboviruses, Marseille, France.
Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France.

Franck de Laval (F)

French Military Health Service, French Armed Forces Centre for Epidemiology and Public Health (CESPA), Marseille, France.
Aix-Marseille University, INSERM, IRD, SESSTIM (Economic and Social Sciences, Health Systems, and Medical Informatics), Marseille, France.

Albane de Bonet d'Oléon (A)

French Military Health Service, French Armed Forces Centre for Epidemiology and Public Health (CESPA), Marseille, France.

François Xavier Le Flem (FX)

Marseille Battalion of Navy Firefighters, 9 boulevard de Strasbourg, 13233 Marseille Cedex 20, France.

Yann Morin (Y)

French Military Health Service, French Armed Forces Centre for Epidemiology and Public Health (CESPA), Marseille, France.

Cyril Badaut (C)

Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France.
Microbiology and Infectious Diseases Department, Institut de Recherche Biomédicale des Armées (IRBA), Brétigny-sur-Orge Cedex, France.

Gilda Grard (G)

French Armed Forces Biomedical Research Institute, National Reference Laboratory for Arboviruses, Marseille, France.
Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France.

Constance Brossier (C)

French Military Health Service, French Armed Forces Centre for Epidemiology and Public Health (CESPA), Marseille, France.

Marion Fossier (M)

French Military Health Service, French Armed Forces Centre for Epidemiology and Public Health (CESPA), Marseille, France.

Aissata Dia (A)

French Military Health Service, French Armed Forces Centre for Epidemiology and Public Health (CESPA), Marseille, France.

Flavie Letois (F)

French Military Health Service, French Armed Forces Centre for Epidemiology and Public Health (CESPA), Marseille, France.

Manon Geulen (M)

French Armed Forces Biomedical Research Institute, National Reference Laboratory for Arboviruses, Marseille, France.
Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France.

Géraldine Piorkowski (G)

Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France.

Jean-Baptiste Meynard (JB)

French Military Health Service, French Armed Forces Centre for Epidemiology and Public Health (CESPA), Marseille, France.

Frank Peduzzi (F)

Marseille Battalion of Navy Firefighters, 9 boulevard de Strasbourg, 13233 Marseille Cedex 20, France.

Isabelle Leparc-Goffart (I)

French Armed Forces Biomedical Research Institute, National Reference Laboratory for Arboviruses, Marseille, France.
Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille, France.

Vincent Pommier de Santi (V)

French Military Health Service, French Armed Forces Centre for Epidemiology and Public Health (CESPA), Marseille, France.
University Hospital Institute Méditerranée Infection, Marseille, France.
Aix-Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH